Fundraising FoxSante Health Ventures — Full Portfolio
6 tracked investments · listed companies and verified rows first
Clairity develops direct air capture and mineralization technology to remove carbon dioxide from the atmosphere.
CleantechClimate TechDeep TechHealthtechSouthern Nevada, US
Glen Meyerowitz(Founder)
Board seatJoe CunninghamKevin Lalande· per SEC Form D · $30M raise · filed Oct 2022
Co-investorsInitialized CapitalLowercarbon CapitalSante Ventures
Lumos Pharma is a clinical-stage biopharmaceutical company developing therapies for rare diseases, with a lead candidate targeting Pediatric Growth Hormone Deficiency.
BiotechHealthtechAustin, US
Richard John Hawkins(Executive Officer, Director)John C. McKew(President and Chief Scientific Officer)inPisit "Duke" Pitukcheewanont(Chief Medical Officer)inLori Lawley(Chief Financial Officer)inBrad Powers(Chief Compliance Officer and General Counsel)inCampbell Murray(Executive Chairman)in
Board seatKevin M. Lalande· per SEC Form D · $13M raise · filed May 2015
Co-investorsNew Enterprise Associates (NEA)Clarus VenturesDeerfield Management CompanySante VenturesWellcome Trust
Focused on Engineered Toxin Bodies immunotoxins for cancer treatment.
BiotechAustin, US
Eric E. Poma(Executive Officer, Director)Jason S. Kim(Executive Officer)David R. Hoffmann(Director)David Hirsch(Director)David Valacer(Executive Officer)Harold Selick(Director)
Board seatKevin LalandeKevin M. Lalande· per SEC Form D · $90.7M raise · filed Jul 2023
Co-investorsLongitude CapitalExcel Venture Management
Sensorium Therapeutics is a clinical-stage biotech company developing novel CNS therapies for anxiety, epilepsy, and cognitive dysfunction using its SensAI platform, which integrates AI, chemistry, and curated natural product data to identify therapeutic patterns from over 50 million biological relationships.
AI & Machine LearningBiotechDigital HealthMedford, US
Jerrold Rosenbaum(Director)inJacob Hooker(Executive Officer, Director)inPranav Tadi(Executive Officer)
BoardRyan Katz(Director)inRichard Simon(Director)
Board seatKevin Lalande· per SEC Form D · $58.5M raise · filed Jul 2025
Co-investorsBonaventure Equity, LLCHatteras Venture PartnersIter InvestmentsMission BiocapitalPalo Santo VCRoute 66 Ventures+3 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.